Aerosolized Nanobodies for SARS-COV-2 Passive Immunization

10/30/2020; 84 minutes

As the world awaits vaccines to bring the COVID-19 pandemic under control, UC San Francisco scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes the disease. They are focused on the potential of virus-neutralizing monoclonal antibodies (mAbs) to treat COVID-19 by passive immunization. Recorded on 10/21/2020. (#36496)

Like what you learn?

Donate to UCTV to support informative & inspiring programming.

Links & Resources

 

SIGN UP FOR EMAIL UPDATES
Subscribe to receive email notifications about featured videos.
(c)2020 Regents of the University of California. All right reserved. Terms and Conditions of Use.